We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Aspirin after Bypass Surgery Reduces Death Risk

By HospiMedica staff writers
Posted on 06 Nov 2002
A study has shown that administering aspirin to patients within 48 hours after heart bypass surgery greatly reduces the risk of death and ischemic complications. More...
The study was published in the October 24, 2002, issue of The New England Journal of Medicine.

The research involved more than 5,000 patients having bypass surgery in 70 hospitals in 17 countries from 1996 to 2000. The hospital death rate among those not given aspirin was 4%, while the death rate for those given aspirin was only 1.3%. The researchers found similar reductions in the rates of stroke, heart attack, bowel damage, and kidney failure caused by low blood flow.

Doctors say the results provides good evidence that aspirin should be given to bypass patients shortly after surgery, except for those who are allergic to aspirin or have bleeding disorders. Some doctors had feared that administering aspirin to bypass patients too soon after their surgery could cause severe bleeding, but the study did not show this. The benefit of aspirin was thought to be twofold: to prevent the formation of blood clots and to reduce the inflammation in blood vessels.

The study was not a randomized controlled trial. However, lead author Dr. Dennis T.Mangano said his team had carefully compared the records of the patients and had found no underlying differences that would explain why those who got aspirin did so much better. Dr. Mangano is the founder of the Ischemia Research and Education Foundation (San Francisco, CA, USA), which sponsored the trial.





Related Links:
Ischemia Research

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.